- Home
- SRTA vs RAPT Comparison
SRTA vs RAPT Comparison
Compare SRTA & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTA
- RAPT
- Stock Information
- Founded
- SRTA 2014
- RAPT 2015
- Country
- SRTA United States
- RAPT United States
- Employees
- SRTA N/A
- RAPT N/A
- Industry
- SRTA
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- SRTA
- RAPT Health Care
- Exchange
- SRTA Nasdaq
- RAPT Nasdaq
- Market Cap
- SRTA 438.4M
- RAPT 498.4M
- IPO Year
- SRTA N/A
- RAPT 2019
- Fundamental
- Price
- SRTA $4.76
- RAPT $28.83
- Analyst Decision
- SRTA Strong Buy
- RAPT Strong Buy
- Analyst Count
- SRTA 1
- RAPT 9
- Target Price
- SRTA $7.25
- RAPT $57.00
- AVG Volume (30 Days)
- SRTA 792.3K
- RAPT 778.5K
- Earning Date
- SRTA 11-10-2025
- RAPT 11-06-2025
- Dividend Yield
- SRTA N/A
- RAPT N/A
- EPS Growth
- SRTA N/A
- RAPT N/A
- EPS
- SRTA 0.50
- RAPT N/A
- Revenue
- SRTA $268,618,000.00
- RAPT N/A
- Revenue This Year
- SRTA N/A
- RAPT N/A
- Revenue Next Year
- SRTA $28.16
- RAPT N/A
- P/E Ratio
- SRTA $10.24
- RAPT N/A
- Revenue Growth
- SRTA 70.11
- RAPT N/A
- 52 Week Low
- SRTA $3.85
- RAPT $5.67
- 52 Week High
- SRTA $6.02
- RAPT $42.39
- Technical
- Relative Strength Index (RSI)
- SRTA N/A
- RAPT 53.26
- Support Level
- SRTA N/A
- RAPT $27.76
- Resistance Level
- SRTA N/A
- RAPT $29.90
- Average True Range (ATR)
- SRTA 0.00
- RAPT 1.66
- MACD
- SRTA 0.00
- RAPT -0.46
- Stochastic Oscillator
- SRTA 0.00
- RAPT 41.72
About SRTA Strata Critical Medical Inc. Class A Common Stock
Strata Critical Medical Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.